Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated ...
Dermatologic diseases, particularly infections and inflammatory conditions, frequently affect displaced persons at Mexico-US ...
The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.
Research now shows that patients dream under anesthesia and report their dreams as uplifting, leading to more positive ...
After stroke, atrial fibrillation is linked to higher inflammation beyond the acute phase; higher high-sensitivity C-reactive ...
Antidepressant therapy may independently improve recovery from dysphagia after acute ischemic stroke through multiple ...
Despite increased STI testing in US emergency departments from 2020 to 2024, syphilis screening is often missed, particularly ...
Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related ...
ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve ...
Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid ...
OSA and planned ICU admission post-tonsil surgery develop early breathing issues that mostly need oxygen or NIV; younger age and nocturnal desaturation predict a higher risk.
A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results